Curatis Holding AG (CHIX:CURNZ) Inventories, Work In Process : CHF0.00 Mil (As of Jun. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Curatis Holding AG Inventories, Work In Process?

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Curatis Holding AG's work in process for the quarter that ended in Jun. 2024 was CHF0.00 Mil.

Curatis Holding AG Inventories, Work In Process Historical Data

The historical data trend for Curatis Holding AG's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curatis Holding AG Inventories, Work In Process Chart

Curatis Holding AG Annual Data

Trend

Dec21

Dec22

Dec23

Inventories, Work In Process

Curatis Holding AG Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Inventories, Work In Process	Get a 7-Day Free Trial			-	-	-	-	-

Curatis Holding AG Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

Curatis Holding AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curatis Holding AG (CHIX:CURNz) » Definitions » Inventories, Work In Process

Comparable Companies

Traded in Other Exchanges

CURN:Switzerland

Address

Weierweg 7, Liestal, CHE, CH-4410

Website

https://www.curatis.com

Curatis Holding AG is a specialty pharmaceutical company based in Switzerland. It focus on the acquisition, development and commercialisation of medicines for the prevention, diagnosis and treatment of rare and specialty care diseases. Curatis is engaged in two business areas: Distribution business for orphan disease and specialty care medicines and Development business for orphan and specialty care disease medicines. Its product include Aggrastat (Tirofiban), AmbiFul (Fulvestrant), Brinavess (Vernakalant), Coldistop, Cuprior (Trientin), Cyanokit (Hydroxocobalamin), etc.

Curatis Holding AG Headlines

No Headlines